Everninomicin biosynthetic genes
View Patent ↗This invention is directed to nucleic acids which encode the proteins that direct the synthesis of the orthosomycin everninomicin and to use of the nucleic acids and proteins to produce compounds exhibiting antibiotic activity based on the everninomycin structure. The DNA sequence for the gene clusters responsible for encoding everninomicin biosynthetic genes, which provide the machinery for producing everninomicin, are provided. Thus, this invention provides the nucleic acid sequences needed to synthesize novel everninomicin-related compounds based on everninomicin, arising from modifications of the DNA sequence designed to change glycosyl and modified orsellinic acid groups contained in everninomicin. A Micromonospora site-specific integrase gene is also provided, which can be incorporated in a vector for integration into any actinomycete, and, particularly into Monospora . Thus, the invention further provides methods for introducing heterologous genes into an actinomycete chromosome using this particular vector.
1. An isolated polynucleotide encoding a polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 177.
2. The polynucleotide of claim 1 which comprises the nucleotide sequence set forth in SEQ ID NO: 176.
3. An isolated vector comprising the polynucleotide of claim 1 .
4. The vector of claim 3 which is a plasmid.
5. The vector of claim 3 further comprising a heterologous gene.
6. An isolated host cell comprising the vector of claim 3 .
7. A method of making the host cell of claim 6 comprising introducing the vector into the cell.
8. The host cell of claim 6 which is an E.coli cell, actinomycete cell, a Streptomyces cell, a Micromonospera cell, a S. pristinaespiralis cell, a S. antibioticus cell, a S. bikiniensis cell, a S. parvulus cell, a S. glauescens cell, a S. actuosus cell, a S. coelicolor cell, a S. ambofaciens cell, a S. lividans cell, a S. griseofuscus cell or a S. limosus cell.